Literature DB >> 15277673

In vivo positron-emission tomography imaging of progression and transformation in a mouse model of mammary neoplasia.

Craig K Abbey1, Alexander D Borowsky, Erik T McGoldrick, Jeffrey P Gregg, Jeannie E Maglione, Robert D Cardiff, Simon R Cherry.   

Abstract

Imaging mouse models of human cancer promises more effective analysis of tumor progression and reduction of the number of animals needed for statistical power in preclinical therapeutic intervention trials. This study utilizes positron emission tomography imaging of 2-[18F]-fluoro-deoxy-D-glucose to monitor longitudinal development of mammary intraepithelial neoplasia outgrowths in immunocompetent FVB/NJ mice. The mammary intraepithelial neoplasia outgrowth tissues mimic the progression of breast cancer from premalignant ductal carcinoma in situ to invasive carcinoma. Progression of disease is clearly evident in the positron emission tomography images, and tracer uptake correlates with histological evaluation. Furthermore, quantitative markers of disease extracted from the images can be used to track proliferation and progression in vivo over multiple time points.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15277673      PMCID： PMC509219          DOI： 10.1073/pnas.0404396101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


  26 in total

1.  Comparison of 3-D maximum a posteriori and filtered backprojection algorithms for high-resolution animal imaging with microPET.

Authors:  A Chatziioannou; J Qi; A Moore; A Annala; K Nguyen; R Leahy; S R Cherry
Journal:  IEEE Trans Med Imaging       Date:  2000-05       Impact factor: 10.048

Review 2.  Use of positron emission tomography in animal research.

Authors:  S R Cherry; S S Gambhir
Journal:  ILAR J       Date:  2001

Review 3.  Fundamentals of positron emission tomography and applications in preclinical drug development.

Authors:  S R Cherry
Journal:  J Clin Pharmacol       Date:  2001-05       Impact factor: 3.126

4.  Standardized uptake values of fluorine-18 fluorodeoxyglucose: the value of different normalization procedures.

Authors:  A Schomburg; H Bender; C Reichel; T Sommer; J Ruhlmann; B Kozak; H J Biersack
Journal:  Eur J Nucl Med       Date:  1996-05

5.  Transgenic Polyoma middle-T mice model premalignant mammary disease.

Authors:  J E Maglione; D Moghanaki; L J Young; C K Manner; L G Ellies; S O Joseph; B Nicholson; R D Cardiff; C L MacLeod
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

Review 6.  Validity of mouse mammary tumour models for human breast cancer: comparative pathology.

Authors:  R D Cardiff
Journal:  Microsc Res Tech       Date:  2001-01-15       Impact factor: 2.769

Review 7.  The use of genetically altered mice for breast cancer prevention studies.

Authors:  Claudine Kavanaugh; Jeffrey E Green
Journal:  J Nutr       Date:  2003-07       Impact factor: 4.798

Review 8.  Genetically engineered mouse models of mammary intraepithelial neoplasia.

Authors:  R D Cardiff; D Moghanaki; R A Jensen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

9.  Contributions of cell metabolism and H+ diffusion to the acidic pH of tumors.

Authors:  Paul A Schornack; Robert J Gillies
Journal:  Neoplasia       Date:  2003 Mar-Apr       Impact factor: 5.715

10.  Polyomavirus middle T-induced mammary intraepithelial neoplasia outgrowths: single origin, divergent evolution, and multiple outcomes.

Authors:  Jeannie E Maglione; Erik T McGoldrick; Lawrence J T Young; Ruria Namba; Jeffrey P Gregg; Lin Liu; Drew Moghanaki; Lesley G Ellies; Alexander D Borowsky; Robert D Cardiff; Carol L MacLeod
Journal:  Mol Cancer Ther       Date:  2004-08       Impact factor: 6.261
View more
  31 in total

1.  Positron emission tomography imaging of DMBA/TPA mouse skin multi-step tumorigenesis.

Authors:  Tomo-O Ishikawa; Indracanti Prem Kumar; Hidevaldo B Machado; Koon-Pong Wong; Donna Kusewitt; Sung-Cheng Huang; Susan M Fischer; Harvey R Herschman
Journal:  Mol Oncol       Date:  2010-02-02       Impact factor: 6.603

Review 2.  Preclinical imaging of mammary intraepithelial neoplasia with positron emission tomography.

Authors:  Craig K Abbey; Alexander D Borowsky; Jeffery P Gregg; Robert D Cardiff; Simon R Cherry
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-04       Impact factor: 2.673

Review 3.  Folate, DNA methylation, and mouse models of breast tumorigenesis.

Authors:  Joshua W Miller; Alexander D Borowsky; Teresa C Marple; Erik T McGoldrick; Lisa Dillard-Telm; Lawrence J T Young; Ralph Green
Journal:  Nutr Rev       Date:  2008-08       Impact factor: 7.110

4.  [F-18]-Fluoro-2-deoxy-D: -glucose positron emission tomography as a tool for early detection of immunotherapy response in a murine B cell lymphoma model.

Authors:  Coralie Chaise; Emmanuel Itti; Yolande Petegnief; Evelyne Wirquin; Christiane Copie-Bergman; Jean-Pierre Farcet; Marie-Hélène Delfau-Larue; Michel Meignan; Jean-Noël Talbot; Valérie Molinier-Frenkel
Journal:  Cancer Immunol Immunother       Date:  2006-12-14       Impact factor: 6.968

Review 5.  Viscoelastic imaging of breast tumor microenvironment with ultrasound.

Authors:  Michael F Insana; Claire Pellot-Barakat; Mallika Sridhar; Karen K Lindfors
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-10       Impact factor: 2.673

6.  Ferret thoracic anatomy by 2-deoxy-2-(18F)fluoro-D-glucose (18F-FDG) positron emission tomography/computed tomography (18F-FDG PET/CT) imaging.

Authors:  Albert Wu; Huaiyu Zheng; Jennifer Kraenzle; Ashley Biller; Carol D Vanover; Mary Proctor; Leslie Sherwood; Marlene Steffen; Chin Ng; Daniel J Mollura; Colleen B Jonsson
Journal:  ILAR J       Date:  2012

7.  An immunotolerant HER-2/neu transgenic mouse model of metastatic breast cancer.

Authors:  Hong Song; Karineh Shahverdi; David L Huso; Yuchuan Wang; James J Fox; Robert F Hobbs; Barjor Gimi; Kathleen L Gabrielson; Martin G Pomper; Benjamin M Tsui; Zaver Bhujwalla; R Todd Reilly; George Sgouros
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

8.  Detection of in situ mammary cancer in a transgenic mouse model: in vitro and in vivo MRI studies demonstrate histopathologic correlation.

Authors:  S A Jansen; S D Conzen; X Fan; T Krausz; M Zamora; S Foxley; J River; G M Newstead; G S Karczmar
Journal:  Phys Med Biol       Date:  2008-09-09       Impact factor: 3.609

9.  The potential role of systemic buffers in reducing intratumoral extracellular pH and acid-mediated invasion.

Authors:  Ariosto S Silva; Jose A Yunes; Robert J Gillies; Robert A Gatenby
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

10.  Magnetic resonance imaging of the natural history of in situ mammary neoplasia in transgenic mice: a pilot study.

Authors:  Sanaz A Jansen; Suzanne D Conzen; Xiaobing Fan; Erica J Markiewicz; Gillian M Newstead; Gregory S Karczmar
Journal:  Breast Cancer Res       Date:  2009       Impact factor: 6.466
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.